Resistance to apoptosis is an characteristic of cancer cells that serves a critical function in tumor development and represents a target for antitumor therapy. Isoimperatorin (ISOIM), a coumarin compound, exhibits antitumor functions in multiple types of tumor cells. However, its antitumor effects and molecular mechanisms with respect to gastric cancer have not been elucidated. The present study assessed the anti-proliferative and apoptotic effects of ISOIM on human BGC-823 gastric cancer cells and elucidated its underlying molecular mechanisms. Cell proliferation was evaluated using MTT assays. Analysis of cell morphology was performed by hematoxylin and eosin, Hoechst 33258 and acridine orange/ethidium bromide staining. In addition, cell cycle and apoptosis was evaluated using flow cytometry analysis; expression of apoptosis-associated proteins was studied by western blotting. The results of the present study revealed that ISOIM significantly inhibited cell proliferation by arresting the cell cycle at the G 2 /M phase and induced apoptosis by increasing Bcl-2-associated X (Bax) expression with a concomitant decrease in Bcl-2 expression, resulting in a decreased Bcl-2/Bax ratio compared with the control. In addition, ISOIM treatment also resulted in cytochrome c translocating from the mitochondria to the cytosol. Furthermore, caspase-3 was significantly activated in response to treatment with ISOIM, suggesting that apoptosis in BGC-823 cells is induced in the mitochondrial pathway. Taken together, the results of the present study indicate that ISOIM may significantly induce apoptosis in BGC-823 cells and that the pro-apoptotic mechanisms of ISOIM could be associated with the mitochondrial pathway.
Introduction
Apoptosis serves an important function in the normal development and stability of organisms (1) . Apoptosis imbalance is associated with numerous diseases, including developmental defects, autoimmune diseases, neurodegenerative disorders and, in particular, tumor occurrence, development and metastasis (2) . Research on inducing tumor cell apoptosis has become a field of interest in cell biology and the biomedical sciences. The aim of current research on tumor cell apoptosis is to develop safer and more effective therapeutic agents for treating tumors. Isoimperatorin (ISOIM) belongs to the 6,7-furan coumarin family of compounds and is the major effective component in the umbelliferae family, which includes Angelica dahurica, Heracleum, coastal glehnia root, Chinese angelica and Peucedanum ostruthium, and is commonly used in traditional Chinese medicine (3) . ISOIM is a secondary plant metabolite that possesses multiple pharmacological properties, including analgesic, antiviral, antitumor, anti-inflammatory, antibacterial and anti-hypertensive properties (4) (5) (6) (7) (8) . ISOIM may inhibit numerous types of human tumor cell from proliferating, including lung cancer A549, ovarian cancer SK-OV-3, skin cancer SK-MEL-2, glioblastoma XF498, HCT-15 colon cancer and MCF-7 breast cancer cells (4) (5) (6) (7) (8) (9) . A previous study reported that ISOIM may inhibit SGC-7901 cells from proliferating and alter the expression levels of pro-apoptotic and anti-apoptotic proteins (10) . However, the present study has certain limitations, including assessing too few cell lines, not observing cell morphology or detecting the cell cycle.
Therefore, the present study used the stomach cancer BGC-823 cell line as an in vitro model to confirm the effects of ISOIM, assess changes in apoptosis-associated proteins in the B-cell lymphoma 2 (Bcl-2) and caspase-3 families in ISOIMtreated cells and to determine the molecular mechanism of ISOIM-induced BGC-823 cell apoptosis. /ml). Following incubation for 24 h, cells were treated with multiple concentrations of ISOIM (0.025, 0.05, 0.10, 0.15 and 0.2 mM) for 48 h. Subsequently, the medium was discarded and 20 µl MTT (5 mg/ml) was added to each well. Cells were incubated for 4 h at 37˚C, after which the medium was replaced with 150 µl dimethyl sulfoxide. The optical density was measured using a microplate reader (Enspire; PerkinElmer, Inc., Waltham, MA, USA) at 490 nm.
Materials and methods

Reagents
Hematoxylin and eosin (H&E) staining of BGC-823.
H&E staining was performed as previously described (8); the treatment group cells were treated with 0.1 mM ISOIM for 48 h.
Hoechst 33258 and AO/EB staining of BGC-823.
After fixing with 100% methanol for 5 min, cells were washed with PBS twice. BGC-823 cells seeded onto coverslips (10 5 /ml) were stained with Hoechst 33258 for 10 min at room temperature and observed using a fluorescence microscope (magnification, x400). The treatment group cells were treated with 0.1 mM ISOIM for 48 h. For AO/EB staining, after washing with PBS three times, the control and treated groups were stained with AO/EB staining solution (10 µg/ml) at room temperature for 3 min and observed using a fluorescence microscope (magnification, x200).
FCM analysis the cell cycle of BGC-823. FCM assays were performed as previously described (11) . Treatment group cells were treated with 0.05, 0.10 or 0.15 mM ISOIM for 48 h. Western blot analysis. Western blot assays were performed as previously described (12) . Treatment group cells were treated with 0.05, 0.1 and 0.15 mM ISOIM for 48 h at 37˚C.
Statistical analysis. Statistical analysis was performed using SPSS software (version 19.0; SPSS, Inc., Chicago, IL, USA), including the calculation of half-maximal inhibitory concentration (IC 50 ). Data were represented as mean ± standard deviation from at least 3 independent experiments. Student's t-test or one-way analysis of variance followed by by Bonferroni's test was used for comparison of 2 or >2 datasets, respectively. P≤0.05 was considered to indicate a statistically significant difference.
Results
Anti-proliferative effects of ISOIM on BGC-823 cells.
Since mitochondrial succinate dehydrogenase in living cells may reduce MTT to a bluish-purple, water-insoluble crystal, MTT is used to detect the number of viable cells and the proliferation of cells. In the present study, multiple gastric cancer cell lines were assessed, including BGC823 (IC 50 =0.115 mM), HGC-27 (IC 50 =0.120 mM) and MGC-803 (IC 50 =0.146 mM). The BGC-823 cell line was the most sensitive to ISOIM of these cell lines and was therefore chosen for further study. ISOIM inhibited BGC-823 cell proliferation in a dose-and time-dependent manner (Fig. 1) . The cytotoxic effect was increased in BGC-823 cells following increasing the concentrations of ISOIM (0.025, 0.05, 0.10, 0.15 and 0.2 mM). The inhibition rate of cells treated with ISOIM for 48 h ranged between 7.69 and 74.92%.
Cell shape changes in BGC-823 cells induced by ISOIM.
Microscopic observation (Fig. 2) revealed that BGC-823 cells exhibited morphological changes in apoptotic cells following ISOIM treatment, including decreased size, cell membrane shrinkage, nuclear pyknosis, decreased numbers of nucleoli, highly condensed nuclear chromatin, budding and foaming from the cell membrane (Fig. 2B, D and F) .
Following Hoechst 33258 staining, an uneven distribution, condensation and karyorrhexis of nuclear fluorescence appeared in BGC-823 cells treated with ISOIM (Fig. 2D) . Following AO/EB staining, nuclear chromatin turned green; pyknotic shaped or round beads represented early apoptotic cells. Nuclear chromatin turned orange; pyknotic shaped or round beads represented late apoptotic cells. Numerous apoptotic cells were observed in BGC-823 cells treated with ISOIM (Fig. 2F) . Control group cells were shown in Fig. 2A, C and E. (Fig. 3B) .
ISOIM-induced cell cycle changes in BGC-823 cells. To assess how ISOIM induced apoptosis in BGC-
Effect of cell apoptosis in BGC-823 cells induced by ISOIM.
The cell apoptosis rate in cells treated with ISOIM was also assessed using FCM. The cell apoptosis rate reached 23.77% while the early apoptosis rate was 13.43% under 0.1 mM ISOIM treatment (Fig. 4) . The results of the present study confirmed the pro-apoptotic effect of ISOIM on BGC-823 cells.
Alterations in apoptosis regulatory proteins induced by ISOIM in BGC-823 cells.
To further evaluate the potential mechanism of ISOIM-induced apoptosis, the present study analyzed the effect of ISOIM on the levels of apoptosis regulatory proteins using western blotting. The levels of cytochrome c and caspase-3 increased following treatment with ISOIM compared with those of the untreated controls (Fig. 5) , which induced a cascade of caspase activity (P≤0.01) that resulted in mitochondria-mediated apoptosis. Furthermore, the levels of Bax increased (P≤0.01) and the Bcl-2 levels decreased (P≤0.05), resulting in a decrease in the anti-apoptotic/pro-apoptotic (Bcl-2/Bax) protein ratio prior to and following ISOIM treatment.
Discussion
Mitochondria serve a key function in the intrinsic apoptosis pathway (13) (14) (15) . Previous studies have indicated that coumarin compounds induce apoptosis in cells via a mitochondria-dependent pathway (16) (17) (18) (19) . Consequently, the primary aim of the present study was to assess the potential mechanism by which ISOIM induces human BGC-823 gastric cancer cells to undergo apoptosis.
In the present study, the dose-and time-dependent proliferation inhibition of BGC-823 cells by ISOIM was demonstrated. Previous studies have revealed that ISOIM may induce apoptosis in multiple types of human malignant tumors (9, 20, 21) . The results of the present study indicated that, following treatment with 0.1 mM ISOIM for 48 h, a substantial degree of apoptosis in BGC-823 cells was detected. As a coumarin compound, the effects of ISOIM on BGC-823 cells corresponded to previous reports of the effects of other coumarin compounds on human breast cancer MCF7, human monocyte U937, mouse hepatocellular carcinoma Hepa-1, mouse adipocyte 3T3-L1, ovarian cancer, and human HL-60 and NALM-6 leukemia cells (14-16,22-25) . The results of cell cycle analysis in the present study confirmed that ISOIM could significantly arrest the BGC-823 cell cycle at the G 2 /M phase and inhibit tumor cells from dividing, inducing apoptosis. The results of the present study on the cell cycle were consistent with the results of a prior study pertaining to the effects of other coumarin compounds on other types of tumor cell (17) .
The Bcl-2 family are major regulators during the release of mitochondrial apoptotic factor (18) . Bcl-2 functions in regulating mitochondrial permeability transition (pore opening and closing of apoptotic factors) is considered to be a primary regulator of apoptosis (26, 27) . Bax functions by releasing cytochrome c, and that Bax transfers from the cytoplasm to the mitochondrial membrane under the stimulus of apoptotic signals and subsequently activates mitochondrially mediated apoptosis (28) . Bcl-2 is an anti-apoptotic protein that inhibits the promotion of apoptosis proteins on the mitochondrial membrane by forming oligomers that affect their anti-apoptotic functions (29) . In addition, the caspase family functions crucially in mediating cell apoptosis (30) . Caspase-3, which is downstream of the apoptosis cascade, is a crucial effector caspase and facilitates apoptosis; it serves as the main effector of apoptosis and the convergence point of apoptotic signaling (31) . Activated caspase-3 indicates irreversible apoptosis (32) . Therefore, the expression of caspase-3 reflects the level of apoptosis and the existence of an apoptosis promoter (33) . To clarify whether ISOIM induces apoptosis in BGC-823 cells via the mitochondrial pathway, the present study evaluated the expression of Bcl-2, Bax, caspase-3 and cytochrome c using western blotting. The results demonstrated that ISOIM downregulated the levels of Bcl-2 and upregulated the levels of cytochrome c, caspase-3 and Bax. The results of the present study revealed that caspase-3 was activated by ISOIM in a dose-dependent manner, and that ISOIM induced human gastric cancer cells to apoptosis. In vitro and in vivo analysis is a useful strategy for assessing anticancer drugs. The present study used in vitro analysis and demonstrated that ISOIM may induce apoptosis and its potential molecular mechanism; however, one deficiency of the present study is the lack of in vivo data, which should represent a future research direction in this field.
To conclude, the present study established that ISOIM, by activating pro-and anti-apoptotic genes, inhibits the cell cycle of BGC-823 gastric cancer cells at the G 2 /M transition, inhibits proliferation and induces the apoptosis of BGC-823 cells by initiating the activation of the mitochondrial pathway. Therefore, further assessing the mechanism of ISOIM, a anticancer compound, in inducing the apoptosis of human BGC-823 gastric cancer cells may be important in preventing this disease and anticancer research.
